Literature DB >> 26115745

Arthrodesis of proximal inter-phalangeal joint for hammertoe: intramedullary device options.

Matteo Guelfi1,2, Andrea Pantalone3, Janos Cambiaso Daniel4, Daniele Vanni3, Marco G B Guelfi5, Vincenzo Salini3.   

Abstract

BACKGROUND: Proximal inter-phalangeal (PIP) joint arthrodesis today represents the standard treatment for structured hammertoes; however, recently, a lot of new intramedullary devices for the fixation of this arthrodesis have been introduced. The purpose of this work is to look at the currently available devices and to perform a review of the present literature.
MATERIALS AND METHODS: A literature search of PubMed/Medline and Google Scholar databases, considering works published up until September 2014 and using the keywords: hammertoe, arthrodesis, PIP joint, fusion, intramedullary devices, and K-wire, was performed. The published papers were included in the present study only if they met the following inclusion criteria: English articles, arthrodesis of PIP joints for hammertoes with new generation intramedullary devices, series with n > 10. Studies using absorbable pins or screws that are considered as another kind of fixation that involved more than one articulation, as well as comments, letters to the editor, or newsletters were excluded.
RESULTS: Nine publications were included. Of the patients' reports, 93-100 % were good or excellent concerning satisfaction. Radiological arthrodesis was achieved in 60.5-100 % of cases. Three of the publications compared the new devices with the K-wire. Of these three articles, two employed the traditional technique and one the buried technique. The AOFAS score, evaluated in three publications, showed a delta of 19, 45 and 58 points. Major complications, which required a secondary surgical revision, were between 0 and 8.6 %. The complications of the K-wire and the new devices were similar; also the reoperation rate was close to equal (maximal difference 2 %). On the other hand, these kinds of devices definitely have a higher price, compared to the K-wire.
CONCLUSION: The use of these new devices provides good results; however, their high price is currently a problem. For this reason, cost-benefit studies seem to be necessary to justify their use as standard treatment.

Entities:  

Keywords:  Arthrodesis; Fusion; Hammertoe; Intramedullary devices; K-wire; PIP joint; Review

Mesh:

Year:  2015        PMID: 26115745      PMCID: PMC4633419          DOI: 10.1007/s10195-015-0360-0

Source DB:  PubMed          Journal:  J Orthop Traumatol        ISSN: 1590-9921


Introduction

Nowadays, the treatment of the hammertoe is still disputable; indeed, a lot of procedures, both on the soft tissues and the bone structures are purposed and considered efficient. In the rigid and structured deformities not suited for manual correction, arthrodesis of the proximal inter-phalangeal (PIP) joint represents the standard treatment [1]. This procedure is performed by removing the articular surfaces of the proximal and intermediate phalanges. Many systems such as cannulated screws or absorbable pins have been designed for the fixation of the arthrodesis, yet still the K-wire is the traditional method, and most utilized [2-6]. However, recently, new intramedullary devices have been used persistently, trying to solve problems such as infections [3, 7], traumatic breaks [8, 9] and malalignments [10] tied to the K-wire. As of today (September 2014), after accurate research, 16 different devices are available on the United States (US) and European (EU) markets. These were divided into four categories according to technical features and material composition (Table 1).
Table 1

Intramedullary devices available on US and EU markets (up to September 2014)

CategoryNameCompanyMaterialNo. of sizes availablePlantar angle
Shape memorySmart Toe® IIStryker® Memometal Nitinol6 + 2 × DIP0°–10°
Hammerlock® BME® Memometal Nitinol4 + 1 × DIP0°–10°
One-piece solid or cannulatedProToe VO® Wright® Stainless steel50°–10°
Arrow-lok™Arrowhead Medical® Stainless steel80°–10°
Ipp On® Integra® Stainless steel2
Proxifuse™Cartiva® Nitinol and PEEK1
Phalinx® Wright™Titanium40°–10°a
Digifuse™Metasurg® Titanium2 + 1 × DIP0°–10°
Two Step Imp. Syst.Trilliant Surgical LTD® Titanium3
DuaFit® In 2 BonesPEEK40°–10°–17°a
Toegrip® Synchro Medical® PEEK50°–10°–20°
HammerFix® Extremity Medical™PEEK3
Bone allograftTenFuse® Solana Surgical® Bone allograft20°–10°
Two-pieceStayfuse™Tornier® Titanium3 Prox/6mid
Nextra® Nextremity Solutions® Titanium2 Prox/3 mid10°
Hat-Trick® Smith and Nephew® PEEK4 Prox/2 mid0°–10°

a10° and 17° angolated are solid, not cannulated

Intramedullary devices available on US and EU markets (up to September 2014) a10° and 17° angolated are solid, not cannulated Shape memory devices: these are composed of a memory metal (Memometal NiTinol), which is activated by body temperature, modifying its shape once implanted. Specifically, these become shorter and enlarge themselves to bestow more stability to the system. Bone allograft devices: since these devices are grafts, they have bone inductive and conductive properties, which improve their integration significantly. One-piece solid or cannulated devices: thanks to the form of their extremities, these can be anchored to the cortical of the proximal and middle phalanges. The cannulated type also permits the use of the K-wire as a guide. With these devices the proximal part is threaded and screwed onto the proximal phalange, while the distal part is anchored to the middle phalange. They are available in steel, titanium or polyetheretherketone (PEEK). Two-piece devices: a female and a male part make up these devices. Once positioned, one on the proximal phalanges, and the other one on the middle, these are fixed together. The purpose of this work is to look at the currently available devices and to review, from the literature, the results of these for PIP fusion.

Materials and methods

A literature search of PubMed/Medline and Google Scholar databases, considering works published up until September 2014, and using the keywords: hammertoe, arthrodesis, PIP joint, fusion, intramedullary devices, and K-wire was performed. The published papers were included in the present study only if they met the following inclusion criteria: English articles, arthrodesis of PIP joints for hammertoes with new generation intramedullary devices, series with n > 10. Studies using absorbable pins or screws that are considered as another kind of fixation that involved more than one articulation, as well as comment, letter to editor or newsletters were excluded. The search strategy identified over 455 articles. A total of 43 publications describing specifically the arthrodesis of the PIP joint for hammertoe could be identified. Thirty-four articles were excluded due to exclusion criteria, these being: studies using absorbable pins, screws or other kinds of fixation (n = 23), fewer than ten patients (n = 9), non-English language (n = 1), comment (n = 1) (Fig. 1).
Fig. 1

Flowchart of eligible study evaluation

Flowchart of eligible study evaluation Nine articles, finally, met the inclusion criteria and were compatible with our review (Table 2) [5, 10–17]. In these papers, patient satisfaction, achievement of arthrodesis, AOFAS score and the rate of complications were taken into consideration.
Table 2

Results of the reviewed articles

ReferencesLevel of evidenceDeviceToes/no. patientsPatients’ satisfaction (%)Acceptable alignment (%)Radiological arthrodesis (%)AOFAS variation (preoperative/postoperative)K-wire revision surgery (%)Device revision surgery (%)
Angirasa et al. J Foot Ankle Surg [11]IV, retrospective case seriesSmart Toe® 13/1398.3NA100NA00
Catena et al. Foot Ank Int [12]IV, case seriesSmart Toe® 42/241001008119 (52/71)NA0
Coillard et al. Foot Ank Int [13]IV, prospective case seriesIpp-On® 156/1179895.983.845 (40.4/84.3)NA0.6
Ellington et al. Foot Ank Int [14]IV, retrospective case seriesStayfuse® 38/27NA81.660.5NANA7.9
Fazal et al. Foot Ank Int [15]IV, retrospective case seriesStayFuse® 150/14095NA7358.7 (22.9/81.6)NA3.3
Roukis et al. Foot Ankle Spec [10]IV, retrospective case seriesSmart Toe® 30/10NANA93NA00
Sandhu et al. Foot Ankle Spec [16]IV, case seriesSmart Toe® 65/35NANA93.8NANA0
Scholl et al. J Foot Ankle Surg [17]IV, retrospective case seriesSmart Toe® 58/NANA87.968.9NA10.78.6
Scott et al. Foot Ankle Spec [5]IV, case seriesProToe® 63/NANANANANANA0

NA not available, AOFAS American Orthopaedic Foot and Ankle Society Forefoot score

Results of the reviewed articles NA not available, AOFAS American Orthopaedic Foot and Ankle Society Forefoot score

Results

The results from the nine articles included in the work are reported in Table 2. The satisfaction of the patient, taken into consideration in four publications, reports a good/excellent result in 93–100 % of the cases [11–13, 15]. In contrast, radiological arthrodesis is achieved in 60.5–100 % of the cases [4, 11]. This value result is heterogeneous and is barely correlated to the review cases, demonstrating the frequent establishment of a fibrous union. Three publications compare the new devices to the K-wire: two of these use the traditional technique and one the buried technique. The Angirasa et al. and Roukis et al. publications report more satisfaction for the devices, yet none of these works cite any cases of revision [10, 11]. The Scholl et al. [17] group, instead, reports no significant difference of revisions utilizing K-wire with the buried technique (8.6 % against 10.7 % p = 0.754). The AOFAS score (evaluated in three publications) shows a delta of 19, 45 and 58 points [12, 13, 15]. Minor complications, often asymptomatic and radiologically identified have been: malunion (2.4–7 %) [5, 10], displaced fixation (1.5–13 %) [10], mallet toe (2–23 %) [10, 13], non union (1.5 %) [16], hardware failures (3–5 %) [12, 16] and ruptures (5 %) [12]. The major complications, which required a surgical revision, vacillate between 0 and 8.6 %. These complications were mainly due to malunion, breaks or recurrence. In conclusion, only two works took the price of the devices into consideration; Coillard et al. reported a 20 times higher price of these devices compared to the K-wire [13]. Ellington et al., instead, reported a price of $225 per device (StayFuse™, Nexa Orthopaedics, San Diego, CA) [14].

Discussion

Although hammertoe is a very frequent disease, the treatment is still heavily disputed. In the structured deformities not suited for manual correction, PIP fusion is considered, today, the standard treatment [4]. The K-wire technique is the most utilized method for performing the fusion, as it is fast, cheap and simple to implant [3]. On the other hand, this kind of fixation method also has weak points: the exterior communication that predisposes for infections and traumatisms, the violation of the distal inter-phalangeal (DIP) joint, the lack of compression and rotational control and, finally, discomfort at removal [3, 7–10]. Because of this, the intramedullary devices aim to solve the weak points of the K-wire technique. Indeed, the results reported above seem to be slightly better than those of the K-wire, especially regarding patient satisfaction and malalignment of the arthrodesis. Considering everything, the type of complications reported for the new devices and the K-wire treatment have been similar, save the superficial infections. Taking into consideration the major complications, in other words the cases which needed a reoperation in the articles that directly compare the new devices to the K-wire, no differences were found [10, 11], or in any case no statistically significant differences [17]. On the other hand, as reported by Ellington and Coillard, the devices definitely have higher prices compared to the K-wire, which represents a limit to their utilization, especially in the case of multiple toe corrections [13, 14]. Currently, no evidence exists in the literature which justifies the use of these new devices, especially considering their high price. For this reason cost-benefit studies are necessary to understand whether lower reoperation rates can justify the use of these devices as the new standard treatment in the future for hammertoes. Regarding reoperation, this can also result in difficulties, especially in the phase of the removal of the device, and cause an excessive reduction of the toe length. For this reason new materials such as PEEK aim to make the revision easier. Of the 16 devices currently available on the US and EU markets, as reported in Table 2, only four are also described in the literature (according to the criteria previously mentioned) and did not show significant differences in their results. For the remaining devices, future studies are still necessary. In conclusion, the new intramedullary devices represent an interesting topic because of their continuous evolution and the constant birth of new devices on the market with new characteristics and material compositions. The use of these devices seem to provide good results; however, the dilemma tied to their high price is not negligible. For this reason, cost-benefit studies that are still lacking in the literature seem necessary to justify the supremacy and the use of the new devices in the future as standard treatment for hammertoes.
  17 in total

1.  Digital arthrodesis with a one-piece memory nitinol intramedullary fixation device: a retrospective review.

Authors:  Jaytinder S Sandhu; William T DeCarbo; Mark H Hofbauer
Journal:  Foot Ankle Spec       Date:  2013-10

Review 2.  Digital arthrodesis.

Authors:  Charles M Zelen; Nathan J Young
Journal:  Clin Podiatr Med Surg       Date:  2013-07       Impact factor: 1.231

3.  Stabilization of proximal interphalangeal joint in lesser toe deformities with an angulated intramedullary implant.

Authors:  Jean-Yves Coillard; Gianfranco John Petri; Geert van Damme; Patrick Deprez; Olivier Laffenêtre
Journal:  Foot Ankle Int       Date:  2014-01-09       Impact factor: 2.827

4.  The PROTOE intramedullary hammertoe device: an alternative to Kirschner wires.

Authors:  Ryan T Scott; Christopher F Hyer; Gregory C Berlet
Journal:  Foot Ankle Spec       Date:  2013-06

5.  Kirschner wire breakage after surgery of the lesser toes.

Authors:  C Zingas; D A Katcherian; K K Wu
Journal:  Foot Ankle Int       Date:  1995-08       Impact factor: 2.827

6.  Operative repair of the fixed hammertoe deformity.

Authors:  M J Coughlin; J Dorris; E Polk
Journal:  Foot Ankle Int       Date:  2000-02       Impact factor: 2.827

7.  StayFuse for proximal interphalangeal joint fusion.

Authors:  M A Fazal; Lawrence James; R L Williams
Journal:  Foot Ankle Int       Date:  2013-04-12       Impact factor: 2.827

8.  Arthrodesis of the toe joints with an intramedullary cannulated screw for correction of hammertoe deformity.

Authors:  R Caterini; P Farsetti; U Tarantino; V Potenza; E Ippolito
Journal:  Foot Ankle Int       Date:  2004-04       Impact factor: 2.827

9.  Smart toe® implant versus buried Kirschner wire for proximal interphalangeal joint arthrodesis: a comparative study.

Authors:  Alex Scholl; James McCarty; Desiree Scholl; Alice Mar
Journal:  J Foot Ankle Surg       Date:  2013-06-14       Impact factor: 1.286

Review 10.  Disorders of the lesser toes.

Authors:  Bertil W Smith; Michael J Coughlin
Journal:  Sports Med Arthrosc Rev       Date:  2009-09       Impact factor: 1.985

View more
  3 in total

1.  Prospective, Multicenter, Clinical and Radiographic Evaluation of a Biointegrative, Fiber-Reinforced Implant for Proximal Interphalangeal Joint Arthrodesis.

Authors:  Luke D Cicchinelli; Jurij Štalc; Martinus Richter; Stuart Miller
Journal:  Foot Ankle Orthop       Date:  2020-11-27

Review 2.  Mallet Toes, Hammertoes, Neuromas, and Metatarsophalangeal Joint Instability: 40 Years of Development in Forefoot Surgery.

Authors:  Debbie Y Dang; Michael J Coughlin
Journal:  Indian J Orthop       Date:  2020-01-15       Impact factor: 1.251

3.  Repurposing of antidiabetics as Serratia marcescens virulence inhibitors.

Authors:  Wael A H Hegazy; Maan T Khayat; Tarek S Ibrahim; Mahmoud Youns; Rasha Mosbah; Wafaa E Soliman
Journal:  Braz J Microbiol       Date:  2021-03-08       Impact factor: 2.476

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.